Abstract:
Inosine 5'-monophosphate dehydrogenase (IMPDH) is a rate-limiting enzyme that catalyzes the conversion of IMP to XMP at the branch point of purine nucleotide biosynthesis, leading to the generation of guanine nucleotides. Inhibition of IMPDH results in depletion of guanine nucleotides, prevents cell growth by G1 arrest, and induces cell differentiation in a cell type-specific manner. The molecular and sensing mechanisms underlying these effects are not clear. We have examined the induction of 
Introduction:
Inosine monophosphate dehydrogenase (IMPDH, EC1.1.1.205) catalyzes the ratelimiting step in the de novo synthesis of guanine nucleotides from IMP 1 . This enzymatic activity is the product of two enzymes encoded by separate genes that have 84% amino acid identity 2 .
One of the isoenzymes, IMPDH type II, is expressed at significantly higher levels in most tissues 3 and is markedly up-regulated in proliferating, as compared to resting, cells 4, 5 . Inhibitors of IMPDH have been developed as immunosuppressive agents and are highly effective at decreasing T and B cell responses in vitro 6, 7 and in vivo 8, 9 . Reversal of the in vitro antiproliferative effects are routinely seen with repletion of the guanine nucleotide pools through the salvage pathway, thereby establishing a direct relationship of the biological activity with guanine nucleotide depletion. The clinical utility of this class of drugs currently ranges from use in combination with other immunosuppressive agents in organ transplantation 10 and graft versus host disease 11 to the treatment of autoimmune disorders such as inflammatory skin diseases 12 and vasculitides such as Wegener's granulomatosis 13 .
The antiproliferative effects of IMPDH inhibition and consequent guanine nucleotide depletion have been investigated in many cell culture systems. Effects include a cell cycle arrest in late G1, inhibition of pRB phosphorylation in peripheral blood lymphocytes, and decreased expression of several proteins important for cell cycle progression including c-myc, cyclin D3, and cdk 4 and 6 14, 15 . The IMPDH inhibitor, Tiazofurin, also induced downregulation of the expression of c-Ki -ras , c-Ha-ras, as well as G protein-mediated transmembrane signaling 14, 16, 17 . Inhibition of IMPDH activity has resulted in differentiation of a number of cell lines 18, 19 , while the induction of apoptosis has been limited to only a few cell types 20, 21 .
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For personal use at PENN STATE UNIVERSITY on February 23, 2013. bloodjournal.hematologylibrary.org From Mycophenolic acid (MPA), a highly specific, uncompetitive inhibitor of IMPDH, was tested against the panel of 60 cell lines at the National Cancer Institute (http://dtp.nci.nih.gov) and found to have growth inhibitory effects against the majority of neoplastic cell types, with leukemias being the most sensitive; however, MPA did not have significant cytotoxic activity in this screen. None of these cells were dependent for proliferation on the presence of specific growth factors or cytokines other than those present in bovine serum. We have now found that MPA is able to induce apoptosis in three murine hematopoietic cell lines of diverse lineages that share the characteristic of interleukin-3 dependence. We have used the well-defined signaling pathways in these cells to determine how MPA interferes with cell survival signals induced by this cytokine. These studies should lay the foundation for the use of IMPDH inhibitors as chemotherapeutic effects in some hematological malignancies, especially in combination with other chemotherapeutic agents or metabolic inhibitors.
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Materials And Methods:
Cell culture and reagents: The murine myeloid cell line 32D and the pre-B cell line BaF3 were maintained in RPMI-1640 medium supplemented with 10% heat-inactivated fetal bovine serum (FBS, Hyclone, Logan, Utah) and 10% WEHI-conditioned medium as a source of IL-3. The murine pre-B cell line FL5.12 (a gift from Craig B. Thompson, University of Pennsylvania, Philadelphia, PA) was cultured in RPMI-1640 medium supplemented with 10% heat-inactivated FBS, 20 mM HEPES, 55 µM 2-mercaptoethanol and 10% WEHI conditioned-medium. All cell cultures were maintained in the presence of 100 µg/ml Penicillin, 100 µg/ml streptomycin. Mycophenolic acid (MPA) was purchased from Sigma (St. Louis, MO) and solubilized in ethanol. MEK1/2 inhibitor (UO126) was obtained from Cell Signaling Technology (Beverly, MA) and dissolved in DMSO. Rapamycin was purchased from CalBiochem (La Jolla, CA) and dissolved in DMSO. Antibodies against phospho-Akt (Ser473), total Akt, phospho-SAPK/JNK (Thr183/Tyr185), total SAPK/JNK, phospho-MEK1/2 (Ser217/221), total MEK1/2, phospho-p44/42 MPA kinase (Thr202/Tyr204), total p44/42 MAP kinase, phospho-p70 S6 kinases (Thr389), total p70 S6 kinase, phospho-Stat3 (Tyr705), phospho-Stat3 (Ser727) and phospho-Stat5 (Tyr694) were purchased from Cell Signaling Technology. Antibody against total Stat3 was obtained from Upstate Biotechnology (Lake Placid, NY). Antibody against 4E-BP1 was obtained from Santa Cruz Biotechnology (Santa Cruz, CA). All control cultures were treated with equivalent amount of reagent diluents. To confirm that the effect of MPA on 32D cells is specifically due to the inhibition of IMP dehydrogenase and consequent depletion of intracellular guanine nucleotides, different ribonucleosides or bases were added to the cultures. Guanosine completely reversed MPA-induced apoptosis (Fig. 2, lane 3) , whereas adenine, adenosine, cytidine and uridine had no affect (Fig. 2, lanes 4-7) . Guanosine also reversed MPA-induced apoptosis in BaF3 and FL5.12 cells (data not shown). Guanosine was used instead of guanine because of its better solubility. Guanine generated from guanosine in the presence of serum containing purine nucleoside phosphorylase activity can be converted to GMP by hypoxanthine-guanine phosphoribosyl transferase 1 , thus circumventing the effect of inhibition of IMPDH on guanine nucleotide levels.
MPA-induced apoptosis occurs in a time-dependent manner, as indicated in Figure 3 . Caspase 3 activity was used as a marker of apoptosis induction and increased by 10-fold after 24 hrs of MPA treatment, with little change at 12 hrs. (Fig. 3A) ; DNA 
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For (Fig. 3B) . Finally, the addition of guanosine at increasing time intervals after MPA addition showed complete prevention of apoptosis at time points up to 12 hrs, but little or no effect after 12 hrs (data not shown). Figure 4 . Effect of MPA treatment on purine nucleotide pools. 32D cells were treated with MPA at 2 µM for the indicated times. GTP (A) and ATP (B) levels were measured by HPLC. This is a representative experiment. Similar results were obtained in at least three other independent assays. The decrease in ATP following MPA treatment was also confirmed by luciferase assays.
Effect of MPA treatment on purine nucleotide pools. 32D cells treated with 2 µM MPA were harvested at various time points for purine nucleotide quantitation. GTP levels were dramatically reduced as early as 30 min after MPA treatment (Fig. 4A) . ATP pools were also decreased, although to a lesser extent after MPA addition (Fig. 4B) 
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For personal use at PENN STATE UNIVERSITY on February 23, 2013. bloodjournal.hematologylibrary.org From Effect of MPA on MEK-Erk, JNK and Akt signaling pathways. One of the major pathways activated following IL-3 stimulation is the Ras-Raf MAPK cascade, which in turn results in the phosphorylation of MEK1/2 and Erk 1 and 2. In order to determine whether the depletion of guanine nucleotides affected these signaling molecules, we determined the levels of the activated, phosphorylated forms of MEK and Erk following MPA treatment (Fig 5) . Both phospho-MEK1/2 and phospho-Erk 1 and 2 were markedly decreased within 1 to 3 hrs after MPA treatment in both 32D (Fig. 5A) and FL5.12 (Fig.   5C ). We have consistently obtained two bands using our phospho-MEK1/2 antibody, although only the upper band is detected using an antibody for total MEK1/2. Since both bands demonstrate similar decreases in intensity after drug treatment, we infer that the bottom band may represent a degradation product of the upper phosphorylated form of MEK. The addition of guanosine reverses the effect of MPA in all instances, confirming that a reduction in guanine nucleotide levels accounts for the alterations in these signaling molecules.
We next determined the effect of MPA on MAP kinase activity.
Immunoprecipitated MEK protein was assayed for its kinase activity using p42 Erk2 as a substrate. Phosphorylated Erk2 then phosphorylates myelin basic protein (MBP) in the presence of [ -32 P] ATP, as described in Methods. As shown in Figure 5B , MEK kinase activity is reduced to less than 50% of control levels after 3 hrs of MPA treatment, a time course that is consistent with the reduction in the level of phosphorylated MEK.
Phospho-Akt was only slightly decreased after approximately 5 hrs of MPA treatment in 32D cells (Fig. 6A ), although this effect was consistently observed. In contrast, the phosphorylation of JNK is clearly increased at 1 to 3 hrs after treatment in only.
For personal use at PENN STATE UNIVERSITY on February 23, 2013. bloodjournal.hematologylibrary.org From Figure 5 . Effect of MPA treatment on MEK-Erk pathway. (A). 32D cells were treated with 2 µM MPA alone or MPA plus 100 µM guanosine (Gua) and cells were harvested at indicated time points. Western blot analysis was performed using antibodies specific for phospho-MEK, phospho-Erk, and total MEK and Erk protein. (B). 32D cells were treated with 2 µM MPA for the indicated time points. 800 µg of total lysate were used for immuno-precipitation with MEK specific antibody, followed by a MEK kinase activity assay using Erk and MBP substrates as described in the Methods. Data are from a representative experiment of two, each performed in triplicate. (C). FL5.12 cells were treated as 32D cells in (A) and harvested at indicated times. 3 µg of total cell lysate was used for both MEK and Erk analysis. Western blot analysis for phospho-and total Akt was performed on 32D cells (A), phospho-and total JNK was performed on both 32D (B) and FL5.12 cells (C). 40 µg of total lysate was used for these blots.
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For personal use at PENN STATE UNIVERSITY on February 23, 2013. bloodjournal.hematologylibrary.org From both 32D and FL5.12 cells (Fig. 6B and C) . Another stress response kinase, p38 MAPK, was not affected by MPA treatment (data not shown). To verify that the downregulation of mTOR pathway following MPA treatment is a specific result of the reduction in GTP and not ATP 25 , we treated 32D cells with either 1 or 2 µM of MPA in the presence of adenine or guanosine. As shown in Figure 7D , guanosine but not adenine completely reversed the MPA effect on phosphorylated p70
S6K. The addition of adenine to 32D cells results in a 1.7-fold increase over control values in ATP levels after 3 hrs (data not shown). Therefore, we conclude that the downregulation of the mTOR pathway in the presence of MPA results directly from effects in the guanine, and not the adenine, nucleotide pools. C.
D.
For However, Stat3 phosphorylated on serine 727 was significantly reduced at 3 hrs following MPA treatment (Fig. 8B) , consistent with the observed down-regulation of the mTOR and MAP kinase pathways after MPA treatment. A.
B.
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For personal use at PENN STATE UNIVERSITY on February 23, 2013. bloodjournal.hematologylibrary.org From resulted in apoptosis equivalent to that seen with MPA treatment (Fig. 9) . This result clearly demonstrated that inhibition of both MAPK and mTOR pathways was sufficient to induce apoptosis in 32D cells, but does not rule out the possibility that MPA may have additional effects outside these two pathways.
only. Despite some initial enthusiasm for use of the drug Tiazofurin as a potential differentiating agent in chronic myelogenous leukemia in blast crisis 30 , IMPDH inhibitors have been used primarily for their immunosuppressive effects.
We have documented that IMPDH inhibition and consequent guanine nucleotide depletion result in apoptosis rather than mere cell cycle arrest at relatively low doses in three IL-3 dependent hematopoietic cell lines. This observation, in conjunction with the cell type specificity, suggests that IL-3 signals that are essential for cell survival are interfered with by limitation of these metabolites. In order to understand the mechanism of action of MPAinduced apoptosis, we have examined the effects of MPA on three major signaling pathways important in IL-3 mediated cellular proliferation.
Activation of caspase 3 was observed after 12 hrs following MPA treatment and the addition of guanosine after this time point was ineffective at preventing apoptosis.
These results signify that commitment to apoptosis requires a relatively long time period after the initial depletion of guanine nucleotides. Of surprise was the observation that only 3 h after drug addition, and coincident with GTP depletion, signaling through both only.
For personal use at PENN STATE UNIVERSITY on February 23, 2013. bloodjournal.hematologylibrary.org From the MEK/ERK and the mTOR pathways was significantly inhibited, as manifested by the decrease in MEK phosphorylation and activity, as well as the decrease in both S6 kinase1 and 4EBP1 phosphorylation. Inhibition of either pathway alone, as carried out through the use of relatively selective pharmacological inhibitors, was ineffective in inducing apoptosis, whereas the combined inhibition of the two pathways was sufficient for this effect.
IL-3 receptors generate several major signals to promote cell growth and survival.
One of these is clearly through the MAP kinase pathway activated through Ras/Raf signaling. It has been demonstrated that c-ras is activated following IL-3 stimulation 31, 32 and that constitutive expression of activated Ras or Raf prevents apoptosis in response to withdrawal of IL-3 [33] [34] [35] . Activated Ras, in addition to many other small G proteins, has a very high affinity for guanine nucleotide binding 36 and it has been thought doubtful that the 80% decline in total intracellular GTP levels induced by MPA would be sufficient to modulate the function of these proteins. However, there is some evidence that free GTP pools as measured by sophisticated patch clamp techniques are significantly lower than total cytoplasmic GTP concentrations and may be in the 50 to 150 µM range as opposed to the mM range 37 . If true, IMPDH inhibition could significantly impair the function of some G proteins.
The second major pathway that is increased through IL-3 stimulation is the mTOR pathway that is regulated both by nutrient deprivation and by mitogen and cytokine stimulation 38 . Activation of p70 S6 kinase results in phosphorylation of the 40S ribosomal protein S6, whereas hyperphosphorylated 4EBP1 causes its dissociation from eIF4E, leading to increased protein translation through 5' capping of specific mRNAs 39 .
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Our studies have clearly demonstrated that MPA treatment reduces the phosphorylated active form of p70 S6 kinase and causes hypophosphorylation of 4EBP1, the latter effect potentially mediating the decreases in c-myc and cyclin D protein translation that have been observed in cells treated with IMPDH inhibitors 14, 15 . Both of these proteins are encoded by mRNAs that contain polypyrimidine tracts and have been shown to be downregulated through inhibition of translation and the mTOR pathway 38, 40 . mTOR itself has been shown to be inhibited by limiting amounts of ATP and to have a very low affinity for this nucleotide, thus acting as a direct and highly sensitive sensor of ATP depletion 25 . However, downregulation of mTOR following MPA treatment is reversed by the addition of guanosine, and not adenine, suggesting that the mTOR pathway is directly affected by depletion of GTP as well as ATP 25 .
A further variable is the observation of JNK activation with MPA treatment. The JNK pathway has been implicated in both apoptosis and survival signaling and JNK phosphorylation frequently reflects a response to cellular "stress" 41 . We hypothesize that the combined effects of MEK inhibition and inhibition of the mTOR pathway are sufficient to result in JNK activation, and have preliminary data to support the induction of JNK phosphorylation in the presence of rapamycin (5µM) and UO126 (10 µM) in combination, but not with either inhibitor alone. Whether or not JNK activation is required for the apoptotic response in IL-3 dependent cells is unclear at present.
Our results clearly do not rule out the possibility that MPA, and by extension guanine nucleotide depletion, has/have effects on additional apoptotic effector mechanisms, but demonstrate that limitation of these important metabolites has an early effect in downregulating at least two signaling pathways important in cytokine-mediated only.
For personal use at PENN STATE UNIVERSITY on February 23, 2013. bloodjournal.hematologylibrary.org From cell survival. Selectivity is evident from the fact that p38 phosphorylation and the tyrosine phosphorylation of Stat 3 and 5 were unaffected. The decrease in the phosphorylation of Stat 3 Ser727 underscores the more proximal effects on the MAP kinase and mTOR pathways, both of which lead to Ser727 phosphorylation 28, 29 . We conclude from these observations that manipulation of intracellular metabolites by inhibitors of selective pathways, such as the purine nucleotide synthetic pathway, may have more complex ramifications on cellular signaling than the use of directed and specific inhibitors that are currently being developed. 
